Cours BioTime, Inc. Nyse
Actions
US09066L1052
Recherche biotechnologique et médicale
CA 2024 * | 17,54 M 16,08 M | CA 2025 * | 14,63 M 13,42 M | Capitalisation | 213 M 196 M |
---|---|---|---|---|---|
Résultat net 2024 * | -21 M -19,25 M | Résultat net 2025 * | -25 M -22,92 M | VE / CA 2024 * | 12,2 x |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 14,6 x |
PER 2024 * |
-9,97
x | PER 2025 * |
-9,11
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 95,87% |
Dernier transcript sur BioTime, Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 52 | 17/09/18 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 14/11/22 |
Chief Operating Officer | - | 01/01/10 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 01/07/09 |
Brian Culley
CEO | Chief Executive Officer | 52 | 17/09/18 |
Director/Board Member | 66 | 11/04/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+0,67% | 42,19 Md | |
+44,30% | 40,15 Md | |
-6,20% | 28,31 Md | |
+6,55% | 24,63 Md | |
-21,66% | 18,2 Md | |
+29,96% | 12,01 Md | |
-1,57% | 11,76 Md | |
+16,03% | 10,4 Md | |
-4,80% | 9,94 Md |